REGRESSION ADJUSTMENT AND STRATIFICATION BY PROPENSTY SCORE IN TREATMENT EFFECT ESTIMATION by Myers, Jessica  A. & Louis, Thomas A.
Biometrics 000, 000000 DOI: 000
000 0000
Regression Adjustment and Stratiﬁcation by Propensity Score in Treatment Eﬀect
Estimation
Jessica A. Myers∗ and Thomas A. Louis∗∗
Department of Biostatistics, Bloomberg School of Public Health
Johns Hopkins University, Baltimore, Maryland, U.S.A.
*email: jamyers@jhsph.edu
**email: tlouis@jhsph.edu
Summary: Propensity score adjustment of eﬀect estimates in observational studies of treatment is a
common technique used to control for bias in treatment assignment. In situations where matching on
propensity score is not possible or desirable, regression adjustment and stratiﬁcation are two options.
Regression adjustment is used most often and can be highly eﬃcient, but it can lead to biased results
when model assumptions are violated. Validity of the stratiﬁcation approach depends on fewer model
assumptions, but is less eﬃcient than regression adjustment when the regression assumptions hold.
To investigate these issues, by simulation we compare stratiﬁcation and regression adjustments. We
consider two stratiﬁcation approaches; equal frequency classes and an approach the attempts to minimize
the mean squared error (MSE) of the treatment eﬀect estimate. The regression approach we consider
is a Generalized Additive Model (GAM), that ﬂexibly estimates the relations among propensity score,
treatment assignment, and outcome. We ﬁnd that, under a wide range of plausible data generating
distributions, the GAM approach outperforms stratiﬁcation in treatment eﬀect estimation with respect
to bias, variance, and thereby MSE. We illustrate approaches via analysis of data on insurance plan choice
and its relation to satisfaction with asthma care.
Key words: Generalized Additive Model; Observational study; Optimal stratiﬁcation; Propensity
score adjustment.
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1. Introduction
In observational studies where investigators seek to estimate the eﬀect of a binary treatment
(treatment and control), treatment assignment is not randomized. As a result, treatment groups
may diﬀer substantially on potentially confounding covariates, biasing estimated treatment eﬀects
(Rubin, 1991; Sommer and Zeger, 1991). Methods available to control for confounding include
regression, matching, and stratiﬁcation on covariates (Cochran, 1968; Billewicz, 1965). Propensity
score methods, developed by Rosenbaum and Rubin (1983), may also be used to balance the
distribution of measured covariates across treatment groups.
The propensity score of an experimental unit is the conditional probability of assignment to the
treatment group, given observed covariates. Under complete randomization, this probability is
controlled by the investigator and is stochastically independent of covariates. When units are not
randomized, the propensity is induced by the assignment process. Speciﬁcally, units (individuals)
that are treated will tend to have higher propensity scores than those who go untreated. This
imbalance in propensity score represents an imbalance on covariates between treatment and
control groups. Methods of adjustment utilizing the propensity, including matching, stratiﬁcation,
and regression adjustment on propensity scores, have been shown to yield unbiased estimates of
treatment eﬀect when the estimand of interest is the expected diﬀerence in response between
treatment and control and treatment assignment is 'strongly ignorable' (Rosenbaum and Rubin,
1983, 1984, 1985; Dehejia and Wahba, 2002).
Matching can be highly eﬀective in removing imbalance in covariates between treatment groups,
but there are often some study units that cannot be matched and must be left out of analysis
(D'Agostino Jr., 1998). The treatment eﬀect estimate will then be based on a reduced, and
potentially non-representative, set of cases. Thus, if investigators wish to estimate average
treatment eﬀect for the entire study population, regression adjustment and stratiﬁcation are both
useful options, but no consensus exists as to which method is preferable under various conditions.
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The utility of each method of adjustment will depend on the mean squared error (MSE) of the
resulting treatment eﬀect estimate with lower MSE preferred.
When using the stratiﬁcation approach, the range of propensity scores is split into strata, and
treatment eﬀect is estimated within each stratum. Then, overall treatment eﬀect is computed
by a weighted mean of the stratum-speciﬁc estimates. Stratiﬁcation on propensity score does
not require speciﬁcation of the propensity-outcome relation, and, therefore, may be preferable to
regression adjustment, especially when this relation is believed to be complex. However, choice of
the number and placement of strata does inﬂuence the variance and bias of the combined estimate.
Generally, there are opposing eﬀects; wide strata produce low variance but high potential bias,
narrow strata the reverse.
The most common implementation of stratiﬁcation on propensity score is ﬁve equal frequency
strata. A result from Cochran (1968), cited in Rosenbaum and Rubin (1983), indicates that
approximately 90% of the initial bias due to the propensity is eliminated by this stratiﬁcation.
Importantly, Cochran's result is based on a linear relation between propensity and outcome.
In other situations, such as those where stratiﬁcation on propensity score is most desirable,
stratiﬁcation on the quintiles, for example, may not adequately remove bias, and other approaches
to forming strata may be preferable. Hullsiek and Louis (2002) propose choosing strata that
balance the variances of the stratum-speciﬁc estimates. This method generally produces an eﬀect
estimate with lower variance than the equal frequency approach because equal frequency strata
with very high estimated variances will be widened to achieve variance balance. Of course, this
widening can increase bias.
Reviews of propensity score methods in published clinical research have found that regression
adjustment by propensity score is the most commonly used method, although investigators often
fail to check the adequacy of their model speciﬁcation (Shah et al., 2005; Weitzen et al., 2004).
When the relation between propensity and outcome is linear, direct adjustment may be achieved
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by including a linear term for propensity in the regression model. In this scenario, regression
adjustment is preferable to stratiﬁcation because it estimates treatment eﬀect with lower variance
than stratiﬁcation and similarly removes nearly all the bias (Rosenbaum and Rubin, 1984, 1983;
D'Agostino Jr., 1998). When the relation between propensity and outcome is not linear, regression
adjustment by propensity score will require more care. Specifying the propensity-outcome relation
in a suitably ﬂexible way, for example using Generalized Additive Models (GAMs) (Hastie and
Tibshirani, 1990), may control bias with a smaller variance than that for stratiﬁcation.
We present a Monte Carlo study comparing the performance of regression adjustment and
stratiﬁcation approaches with respect to variance, bias, and MSE for several data generating
models. The methods considered include equal frequency stratiﬁcation on propensity score, an
'optimal' stratiﬁcation on propensity score that minimizes the estimated MSE of the resulting
treatment eﬀect estimate, and regression adjustment on propensity score using GAMs. We assume
throughout that the propensity score has been estimated well; however, deviations from this
assumption would certainly eﬀect the performance for all of the methods investigated. Section 2
describes notation and the propensity score methods under consideration. Section 3 presents the
simulation study and results. Section 4 presents an analysis of an observational study of the eﬀect
of health insurance type on satisfaction with asthma care. Section 5 summarizes our ﬁndings.
2. Model and Methods
Let Zi indicate treatment assignment, with Zi = 1 for treatment and Zi = 0 for control. Deﬁne
the response vectors accordingly, Y z = (Y1z, Y2z, . . . , Ynzz), where nz is the sample size for
treatment group z. Furthermore, let X i be a vector of potential confounders, associated with
both treatment and outcome. The propensity score is deﬁned ei = e(X i) = Pr(Z = 1|X i). We
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assume linear confounding via the model
Y |z, e = β0 + β1z + g(e) +  (1)
 ∼ N(0, σ2)
where β0 and β1 are scalar parameters and g is some smooth function. Our target of estimation
is the true average treatment eﬀect, given by ∆ = β1.
We are interested in comparing estimation approaches for ∆ with respect to MSE and its
components, variance and bias, which may be summarized:
MSE(∆ˆ) = V ar(∆ˆ) +Bias(∆ˆ)2 (2)
With no confounding, a simple diﬀerence of means, (Y¯1−Y¯0), is minimum variance, unbiased (and
therefore minimum MSE) for estimating the treatment eﬀect. In the presence of confounding,
this estimate is biased. The initial bias for this unadjusted estimate is
Bias(Y¯1 − Y¯0) = E(Y¯1)− E(Y¯0)− β1
=
∫ 1
0
g(u)[f1(u)− f0(u)]du (3)
where f1 and f0 are the densities of propensity scores in the treatment and control groups,
respectively. We consider regression and stratiﬁcation on propensity score for reducing bias in
estimation of ∆.
2.1 Regression adjustment
The assumed model in (1) suggests the use of GAMs for estimating treatment eﬀect. Fitting the
GAM, E(Y |z, e) = β0 + β1z + g(e), treatment eﬀect and variance are returned as the estimate
and variance of the coeﬃcient on treatment, β1. The smooth term for propensity score, g(e), is
approximated as a sum of spline terms. Any of the well-known basis functions may be used in
this sum; we use thin plate regression splines with cross-validated smoothing parameter selection,
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as described in Wood (2003, 2004). This regression model should closely mirror the true data
generating process under our assumed model. If data are generated from another model, for
example, a model with a non-additive eﬀect of treatment, then the GAM will not represent the
data generating process, but may be used for estimation of average treatment eﬀect.
2.2 Stratiﬁcation
Let t = (0 = t0 < t1 < . . . < tK = 1) deﬁne a partition of the range of propensity scores with
K subclasses. Within each stratum, k ∈ {1, . . . , K}, treatment eﬀect is estimated with a simple
diﬀerence of means, ∆ˆk. The variance of the diﬀerence of means is estimated
Vk = σˆ
2
1k/n1k + σˆ
2
0k/n0k (4)
where σˆzk = Vˆ ar(Y |Z = z, tk−1 < e ≤ tk) and nzk is the number of units in treatment
group z and subclass k. The overall treatment eﬀect estimate and its estimated variance is the
inverse-variance-weighted mean of the subclass-speciﬁc estimates, given by
∆ˆ =
(
K∑
k=1
∆ˆkV
−1
k
)
/
(
K∑
k=1
V −1k
)
ˆV ar(∆ˆ) = 1/
(
K∑
k=1
V −1k
)
. (5)
Several authors have noted that the variance estimator given here generally underestimates
the variance of the stratiﬁed treatment eﬀect estimate because it treats the partition as ﬁxed,
rather than data dependent (Tu and Zhou, 2002; D'Agostino Jr., 1998). We use this estimator
nonetheless because we are not primarily interested in the performance of the variance estimator,
and we focus instead on the performance of the treatment eﬀect estimators.
We consider two methods for choosing t. In equal frequency stratiﬁcation, the partition is
deﬁned by the quantiles. As an alternative, we seek to choose a partition that minimizes the MSE
of the combined treatment eﬀect estimate. In order to ﬁnd the optimal partition, we must be
able to estimate the MSE of the inverse variance-weighted estimator of treatment eﬀect for a
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given partition. The estimator for variance is given above in (5). Under the assumed model (1),
a formula for bias in stratum k is given by:
Bias(∆ˆk) = E(Y |Z = 1, e ∈ (tk−1, tk))− E(Y |Z = 0, e ∈ (tk−1, tk))− β1
= E(g(e)|Z = 1, e ∈ (tk−1, tk))− E(g(e)|Z = 0, e ∈ (tk−1, tk))
=
∫ tk
tk−1
g(x)[f1(x)/M1k − f0(x)/M0k]dx (6)
where Mzk =
∫ tk
tk−1
fz(x)dx. This formula can be estimated using the estimated functional form
of the relation between propensity score and outcome, gˆ, returned by the GAM described above.
In addition, we estimate the densities of propensity scores in each treatment group, f1 and f0,
using a simple kernel density estimator.
Overall estimated bias of the treatment eﬀect estimator is the inverse-variance-weighted mean
of the subclass-speciﬁc biases. Using the estimates for bias and variance, we produce a function
that returns the estimated MSE for a given partition, t, and dataset, (y, z, e). The optimal
partition for K subclasses is then found by treating the K − 1 elements of t between 0 and 1 as
the variable parameters in an optimization algorithm for minimizing the estimated MSE function.
3. Simulation Study
As shown in (3) and (6), the amount of bias due to propensity relates to the amount of imbalance
in propensity between the two groups. We consider a class of conditional densities of the propensity
scores in the treatment and control groups, deﬁned respectively by:
f1(e) =
 (2e)
s e ≤ .5
2− (2(1− e))2 e > .5
f0(e) = f1(1− e)
These densities are by construction anti-symmetric (fz(e) = f1−z(1−e)) and produce a marginal
uniform density when there is equal sample size in the two groups. Varying s produces a wide
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range of plausible distributions; an s of zero indicates a uniform distribution in each treatment
group, and a large s indicates an extreme imbalance in propensity score by treatment assignment.
We set pi = P (Z = 1) = 1/2 and generated N = n1 + n0 propensity scores from a uniform
distribution on (0,1). We then assigned treatment indicators according to
Zi ∼ Bernoulli(pif1(ei)). (7)
We consider outcomes generated by two diﬀerent models: the additive model, which is equiv-
alent to the assumed model presented in (1), and the non-additive model,
Yi = exp{β0 + β1zi + g(ei) + i} (8)
i ∼ N(0, σ2).
where, as before, β0 and β1 are scalar parameters and g is a smooth function. For both models, we
consider the treatment eﬀect of interest to be the average diﬀerence in expected outcome between
treatment and control, conditional on propensity score. In the additive model, this quantity is given
by ∆ = ∆(e) = β1. In the non-additive model, this quantity is equal to
∆ =
∫ 1
0
∆(e)dF (e)
=
∫ 1
0
E(Y |Z = 1, e)− E(Y |Z = 0, e)dF (e)
= exp{β0 + σ2/2}(exp{β1} − 1)
∫ 1
0
exp{g(e)}dF (e) (9)
3.1 Simulation Settings
We considered samples of size N = 200 and, as mentioned earlier, set pi = 0.5 to achieve
approximately equal sample size in the two groups and a marginal uniform distribution for
propensity scores. We generated data with three diﬀerent values of s: .5, 1, and 2, corresponding
to low, moderate, and high imbalance, respectively, in propensity scores in the two groups.
Furthermore, for each value of s, four diﬀerent functional forms for g, the relation between
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propensity and outcome, are considered: (A) g(e) = e, (B) g(e) = e2, (C) g(e) = 2(e − .3)2,
and (D) g(e) = .5 + 4(e− .5)3. Each of these functions has an approximate range of [0,1] over
the same domain interval, and, therefore, each induces a similar amount of bias. Relation (A) is
linear, relation (B) is non-linear, but monotonic, relation (C) is non-linear and non-monotonic,
and relation (D) has a non-monotonic ﬁrst derivative. The three values for s and four functions
for g yield 12 simulation scenarios for each of the two models.
In the additive model, we chose β0 = 0, β1 = .25, and σ = .5, so that the true treatment eﬀect is
equal to one half of the error standard deviation. In the non-additive model, we chose β0 = −.125,
β1 = .2, and σ = .5. Because we speciﬁed β0 = −σ2/2 and e ∼ Unif(0, 1), the expression for
the treatment eﬀect in the non-additive model is reduced to (exp{β1}− 1)
∫ 1
0
exp{g(u)}du. We
simulated 1000 datasets under each scenario and each model.
With each simulated dataset, we applied each of the methods presented in Section 2, including:
(1) adjustment by propensity score via a smooth term for propensity score in a GAM; (2) equal
frequency (EF) stratiﬁcation using K = 1 through 6 subclasses; and (3) optimal stratiﬁcation,
using K = 1 through 6 subclasses, chosen such that the estimated MSE of the resulting estimate
is minimized. Additionally, in the simulations generated from the additive model, we use the true
g(e) in a generalized linear model (GLM) to compare with the GAM. In the GLM, the true values
of g(ei) enter the model as an oﬀset, so that only the intercept and treatment eﬀect must be
estimated. Clearly, this model cannot be estimated in practice, since one generally won't know
the true propensity-outcome relation. In this study, we compare the estimates from this model to
that obtained using GAM to show the amount of bias and variance in the GAM estimates that is
due to estimation of the relation g(e).
3.2 Simulation Results
In all of the data-generating scenarios considered, signiﬁcant positive bias exists when treatment
eﬀect is estimated directly, corresponding to stratiﬁcation with K = 1. Initial bias is similar (but
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not constant) across the four propensity-outcome relations because the ranges of these functions
are similar. Varying the amount of imbalance in propensities, indexed by s, varies the amount of
initial bias. Data generated under higher s values produce estimates of treatment eﬀect with higher
initial bias. Data simulated with high imbalance in propensity scores between treatment groups
also suﬀer from lack of suﬃcient overlap; when using the stratiﬁcation approaches, particularly
with datasets simulated under s = 1 or s = 2, the outermost strata contain data from only one
treatment group. Therefore, no treatment eﬀect estimate is possible for those strata, and their
corresponding variance estimates are inﬁnite. In those situations, we allowed the inﬁnite variance
to dictate a zero weight for the data in those strata, so that the number of strata actually used
in treatment eﬀect estimation, denoted by K∗, is smaller than K, the number of strata intended.
In this section, we present a selection of the simulation results, but results for all simulations
discussed are available in Web Supplement A.
Figure 1 shows the average estimated treatment eﬀect with one observed standard error bars
(left panel), observed standard errors and average estimated standard errors with 95% quantile
bars (center panel), and observed root MSE (right panel) for data simulated under the additive
model with linear relation between propensity and outcome (relation (A)). Data is displayed for
simulations using all three values of s and for all analysis approaches considered. The horizontal
axis is K, the number of strata used, where K = 0 refers to the use of non-stratiﬁcation methods,
GLM and GAM. The use of K = 1 means no stratiﬁcation (direct estimation through a simple
diﬀerence of means); these estimates show the amount of initial bias. For K > 2, the number of
simulations out of 1000 that have K∗ = K is printed above the corresponding plotting point for
EF stratiﬁcations, and below the corresponding point for optimal stratiﬁcations.
The treatment eﬀect estimate plots show that the GAM and both stratiﬁcation approaches
are eﬀective at reducing or eliminating bias due to propensity score. In particular, for each value
of s, the GAM produces estimates of treatment eﬀect that are on average unbiased and nearly
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identical to that of the GLM. Estimating the propensity-outcome relation in the GAM increases the
standard error of the treatment eﬀect estimator only slightly compared to the GLM. Bias reduction
through stratiﬁcation is achieved better at larger values of K. The optimal stratiﬁcation method
does slightly outperform equal frequency stratiﬁcation with respect to bias reduction at moderate
values of K, but at large values of K, the bias is equivalent for both stratiﬁcations (or even
slightly favoring EF stratiﬁcation) and the observed standard error is smaller for EF stratiﬁcation.
The standard error plots in Figure 1 conﬁrm that our variance estimator for the stratiﬁed
treatment eﬀects does on average produce estimates of standard error lower than what is observed
across simulations. Observed standard errors generally increase asK increases, although for s = 2,
this is not the case because so many of these datasets had K∗ < K. The standard error estimates
resulting from the GAMs is on average close to the observed standard error and generally lower
than the observed standard errors resulting from stratiﬁcation.
The plots of root MSE (RMSE) in Figure 1 show that in these data the GAM results in lower
RMSE than the stratiﬁcation approaches, regardless of the value of s. The diﬀerences in RMSE
between the GLM, GAM, and stratiﬁcation approaches become larger as s increases. In addition,
RMSE is approximately constant for stratiﬁcation approaches with K ≥ 3. Although we continue
to reduce bias as we increase K, this bias reduction is paid for with increasing variance, thus
leaving RMSE essentially constant.
[Figure 1 about here.]
In Figure 2, we display the same information as that plotted in Figure 1, except for s = .5
only and for propensity-outcome relation (B). The patterns are primarily the same as they were
when the propensity-outcome relation was linear. GAM again provides an unbiased estimate with
equivalent or smaller observed standard error than either stratiﬁcation method. The diﬀerences
in RMSE among estimation methods are again larger at larger values of s. The simulation results
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for relations (C) and (D) are available in the Web Supplement and are similar to the results
presented here.
[Figure 2 about here.]
Figure 3 displays simulation results for data simulated under the non-additive model with s = .5
and propensity-outcome relation (A). There are several diﬀerences in these results compared to
the results plotted in Figure 1 for the additive model. First, the true treatment eﬀect is no longer
equal to β1 = 0.25, but is given by (9). Although the GAM estimates the true treatment eﬀect
well, the stratiﬁed estimates appear to be converging to some negatively biased quantity as K
increases. These stratiﬁed estimates do pass through the truth at K = 3, but of course, a priori
the analyst has no way of knowing which K to choose to achieve these results.
The insuﬃcient overlap in the optimal strata seems to be ampliﬁed in the non-additive data
compared to the additive data. In Figure 3, nearly all of the simulated datasets have K∗ = K
when using EF stratiﬁcation, but many datasets have K∗ < K when using optimal stratiﬁcation.
Also, the GAM is now generally overestimating the standard error of the estimates of treatment
eﬀect compared to that which is observed. In general, the GAM again has lower RMSE than
either stratiﬁcation method, regardless of the number of strata used.
[Figure 3 about here.]
In Figure 4, results are shown, as in Figure 3, for the simulations with propensity-outcome
relation (B). Results are similar to those with propensity-outcome relation (A) and again show
that the GAM outperforms stratiﬁcation. The results for other values of s and the other propensity-
outcome relations (C) and (D) are similar.
[Figure 4 about here.]
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3.3 Generality of Distributional Assumptions
Above, we simulated propensity scores with a Uniform(0,1) marginal density and conditional
distributions that are anti-symmetric. The former assumption is made without loss of generality
because propensity scores not satisfying this condition may be transformed. If the conditional
densities are anti-symmetric and we have equal sample size in each group, the uniform transform
does not corrupt this property; however, if anti-symmetry is not present, it cannot be forced
through a monotone transform.
Let F (e), F1(e), and F0(e) be the cumulative distribution functions of propensity scores,
marginally, in the treated group, and in the control group, respectively. Using F as the uniform
transform, the transformed scores and their conditional distributions are given by
U = F (e)
F ∗z (u) = Fz(F
−1(u))
The conditional distribution of the transformed data is closely related to the conditional distribu-
tion of the untransformed data. Because of this relation, anti-symmetry is preserved under this
transformation, as shown in the Appendix
The preservation of anti-symmetry under the uniformity transform follows from the more general
fact that any monotone transform will preserve anti-symmetry. This property also implies that
no monotone transform will produce anti-symmetry in data where it does not already exist.
Therefore, the results presented above are at least partially generalizable to cases which do not
meet the assumptions held thus far. It is possible that data without anti-symmetric conditional
densities of propensity scores will produce diﬀerent results. In some preliminary investigations of
this possibility, results were very similar when propensity scores were simulated from densities that
were not anti-symmetric.
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4. Analysis of Insurance Plan Choice Data
The following analysis considers data collected on 2515 asthma patients as part of the 1998
Asthma Outcomes Survey (Masland et al., 2000). This study was initiated by the Paciﬁc Business
Group on Health and HealthNet health plan for the purpose of assessing the quality of asthma care
from 20 physician groups. Huang et al. (2005) developed propensity score methods to address
physician group as a multiple treatment analysis. Because we prefer a binary treatment, our
analysis evaluates the eﬀect of health insurance type on satisfaction with asthma care across the
20 providers. Insurance type is classiﬁed as public, purchased through an employer, purchased
personally, or other. A large majority, 2360 individuals, held either employer or personally pur-
chased health insurance, and we consider the subset of data with these two insurance types so
that the treatment of interest is dichotomous. Our indicator of treatment, Z, indicates having
personally purchased health insurance.
The outcome is also dichotomous; Y = 1 indicates very good or excellent satisfaction with care,
and Y = 0 indicates less than very good satisfaction. We are interested in estimating the average
diﬀerence in the probability of high satisfaction with care between individuals with personally
purchased and employer purchased insurance plans, controlling for confounders of treatment
assignment and outcome. Clearly, this example is diﬀerent from the data simulated in the Monte
Carlo studies because those data all had continuous outcomes. However, our goal of estimation
here is the same as in the simulations, and we may expect that the estimation problems faced in
data simulated from the non-additive model will be similar to the problems faced in these data.
Therefore, we follow the suggestion of Hellevik (2008) and use a Gaussian family GAM, exactly
as implemented in the simulations, to estimate treatment eﬀect.
We began by considering the measured covariates available for use in the propensity score, which
include information about demographics, medical care, and health status. Demographic covariates
are age (18-56), race (Black, White, Asian/Paciﬁc Islander, American Indian, Other), Hispanic
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identiﬁcation, gender, educational attainment (high school or less, college, post-graduate work),
and employment status (none, part-time, full-time). Covariates that describe subjects' medical
care are primary physician specialty (pulmonary/allergy specialist, other), consistent care by the
same provider, physician group (1-20), and drug insurance coverage. Health status covariates
include smoking (none, moderate, high), physical activity in the last four weeks (1-7), severity
of asthma (1-4), comorbidity count (0-8), number of years with asthma (1-54), and the SF36
Health Survey composite scores for physical and mental health (0-100).
We must choose, of the measured covariates listed above, which to include in the propensity
score model. Studies of propensity score methods have found that best results are achieved by
only including covariates that are associated with outcome (Austin et al., 2007; Brookhart et al.,
2006). This selection should include all of the potential confounders, those covariates associated
with both treatment assignment and outcome. Therefore, before we estimate any propensity score
models, we check each covariate by ﬁtting a logistic regression model of outcome on treatment
and the covariate. These models allow us to determine if there is an association between covariate
and outcome when controlling for treatment assignment and to order the covariates with respect
to their eﬀect on outcome, as recommended by Hill (2008). For nominal categorical covariates,
we ﬁt simple GLMs, and for continuous or ordinal categorical covariates, we ﬁt GAMs. Checks
of association for the 11 categorical covariates and the 6 continuous covariates, respectively,
are displayed in Web Supplement B. From these ﬁgures, we determined that when adjusting for
treatment only smoking, employment status, and physical activity seem to share no association
with the outcome, satisfaction with asthma care.
In the spirit of ﬂexible model estimation, we used a logistic GAM of the personal health
insurance indicator on the remaining 14 covariates that are associated with outcome to estimate
the propensity score for each individual (Woo et al., 2008). The propensity score obtained is the
predicted probability of holding personally purchased insurance, rather than employer purchased
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insurance, given model covariates. We ran an all subset regression with the eight most important
covariates (always present in the model) and some subset of the other six predictors. We compared
the unbiased risk estimator (UBRE) of these 64 models to identify a smaller set of useful
candidate models. For each candidate model, we then checked the balance of all 14 covariates
associated with outcome to identify our ﬁnal model for propensity score estimation. Balance was
checked through side-by-side boxplots of covariates, stratiﬁed on both treatment and propensity
score quintile, or through two-by-two tables of treatment and covariates within propensity score
quintiles. Figures in Web Supplement B show the balance checks for the ﬁnal model chosen,
which included: (1) random intercepts for physician groups; (2) main eﬀects for race, education,
consistent provider care, drug coverage, years with asthma, physical composite score, and mental
composite score; and (3) a smooth term for age, which we note has a nonlinear relation with the
log odds of treatment. Older and younger adults are more likely to have personally purchased
health insurance than adults in middle-age.
[Figure 5 about here.]
Figure 5 shows the densities of the propensity scores in both treatment groups. The two groups
overlap well with respect to propensity score, and we can estimate average treatment eﬀect for
the entire propensity score range. We next apply each of the three methods considered in the
Monte Carlo study: GAM estimation, EF stratiﬁcation, and optimal stratiﬁcation. In addition,
we compare these propensity score-based methods with the usual regression of outcome on the
covariates used in the propensity score model and the treatment indicator.
Figure 6 displays the treatment eﬀect estimation results of all analysis approaches considered.
All analyses estimate a statistically signiﬁcant or nearly statistically signiﬁcant positive eﬀect of
holding personally purchased health insurance on satisfaction with asthma care. In particular,
the GAM with propensity score approach, estimates that, on average, the probability of being
highly satisﬁed with asthma care is 0.047 (-0.004, 0.097) larger for individuals with personally
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purchased health insurance than individuals with employer purchased health insurance, controlling
for propensity to treatment. This estimate is reduced slightly from the unadjusted treatment eﬀect
estimate, 0.061 (0.015, 0.107). In Web Appendix B, we show the estimated smooth term for
propensity score as estimated by the GAM. There is a small positive relation between propensity
score and outcome, and this association reﬂects the confounded relation between treatment and
outcome.
[Figure 6 about here.]
5. Discussion
The objective of this study was to compare the relative merits of stratiﬁcation and regression
approaches utilizing the propensity score for estimating treatment eﬀects in observational studies
and to explore the potential of an 'optimal' stratiﬁcation procedure. Stratiﬁcation on propensity
score and regression adjustment with a smooth term for propensity score in a GAM both estimate
treatment eﬀect ﬂexibly, allowing for nonlinear association between propensity score and outcome,
and both are eﬀective at reducing bias due to propensity to treatment. Based on the results from
the Monte Carlo simulations, we recommend the GAM approach for three reasons: the GAM
generally produces estimates with lower average bias and variance; the GAM requires less user
choice to achieve bias reduction compared to stratiﬁcation where the analyst must, at minimum,
choose an appropriate K; and, thanks to ﬂexible and automated GAM packages, such as mgcv in
R, the GAM is simpler to implement than even EF stratiﬁcation. In addition, the lack of necessary
user choice in GAMs allows the outcomes to stay hidden until the ﬁnal step of analysis, as
advocated by Rubin (2001, 2007).
The beneﬁts of GAMs in this case do not, however, overcome the need for great care in
propensity score analysis. For example, analysts must still check for covariate balance on esti-
mated propensity score. In the analysis presented in Section 4, we checked approximate balance
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of covariates within propensity score quintile, which ensures unconfounding of treatment and
outcome within quintile. How best to check for balance when the propensity score will be used
in a covariate regression has not been studied. In the Monte Carlo studies, we assumed that we
have a well-estimated propensity score, and that there exists a true smooth relation between
the estimated propensity score and the expectation of outcome. In data where covariates are not
well-balanced by the estimated propensity score, we may expect that these assumptions fail and
the results for all methods considered will be worse than what is presented here.
Estimated propensity scores must also be checked for suﬃcient overlap of treatment groups.
Insuﬃcient overlap may result in a modiﬁed estimand or inappropriate extrapolation, regardless
of the propensity score analysis method used. In particular, in each of the simulations presented
in this paper, we additionally implemented a GAM that estimated a separate smooth term for
propensity score among treated and untreated subjects. We then estimated average treatment
eﬀect using this model to predict the unobserved potential outcomes. We did not present the
results from this method in Section 3.2 because the imbalance in the tails of the propensity score
distributions led to inappropriate extrapolation and extremely poor estimates of average treatment
eﬀect. The GAM with a single smooth term for propensity score is partially protected from this
kind of extrapolation because the estimated eﬀect of treatment is forced to be constant across
the range of propensity scores. Therefore, treatment eﬀect is estimated primarily from data units
that lie in overlapping regions of the propensity score distributions; however, this case may result
in an estimand that is diﬀerent than what the investigator intended.
Finally, we note that regression adjustment may be more problematic when variances diﬀer
between treatment groups. We investigated this possibility in the non-additive simulation studies,
where data was simulated with heteroscedastic errors. The stratiﬁcation approaches allow for
diﬀering variance estimates between treatment groups and across strata. The GAM approach
does not model the heteroscedasticity, but still outperformed stratiﬁcation in these simulations.
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In cases of more extreme imbalance in variances between treatment groups, we may ﬁnd that the
GAM no longer performs well.
Supplementary Materials
Web Appendices and Figures referenced in Sections 3.2 and 4 are available under the Paper
Information link at the Biometrics website http://www.biometrics.tibs.org.
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Appendix Proof of Anti-symmetry Preservation
In this section we prove that when pi = 1/2, anti-symmetry of conditional densities is preserved
under the uniform transform. Recall, anti-symmetry is deﬁned, fz(e) = f1−z(1− e). Equivalently,
we may state, Fz(e) = 1− F1−z(1− e). We must show that F ∗1 (1− u) = 1− F ∗0 (u).
First, note that
F (1− e) = 1
2
F1(1− e) + 1
2
F0(1− e)
=
1
2
[1− F0(e)] + 1
2
[1− F1(e)]
= 1− 1
2
F1(e)− 1
2
F0(e)
= 1− F (e)
⇒ F (1− F−1(e)) = 1− e
⇒ 1− F−1(e) = F−1(1− e).
Then consider
F ∗1 (1− u) = F1(F−1(1− u))
= F1(1− F−1(u))
= 1− F0(F−1(u))
= 1− F ∗0 (u).
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Figure 1. Average estimated treatment effect with one observed standard error bars (left
panel), observed standard errors and average estimated standard errors with 95% quantile
bars (center panel), and observed root MSE (right panel) for data simulated under the
additive model with linear relation between propensity and outcome (relation (A)). Data is
displayed for simulations using all three values of s and for all analysis approaches considered.
The horizontal axis is K, the number of strata used, where K = 0 refers to the use of non-
stratification methods, GLM and GAM, and K = 1 means no stratification (direct estimation
through a simple difference of means).
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Figure 2. Simulation results for data simulated under the additive model with s = .5 and
propensity-outcome relation (B), corresponding to g(e) = e2.
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Figure 3. Simulation results for data simulated under the non-additive model with s = .5
and propensity-outcome relation (A), corresponding to g(e) = e.
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Figure 4. Simulation results for data simulated under the non-additive model with s = .5
and propensity-outcome relation (B), corresponding to g(e) = e2.
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Figure 5. Relative frequencies of the estimated propensity scores conditional on treatment.
Only 26.4% of units had personally purchased health insurance (“Treated”), and 73.6% of
units had employer purchased health insurance (“Untreated”).
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Figure 6. Treatment effect estimates with confidence intervals, using a regular regression
approach (Reg), the GAM with propensity scores approach (GAM), and the optimal (Opt)
and equal frequency (EF) stratification on propensity score approaches.
